Low Risk of Thromboembolic Complications With Tranexamic Acid After Primary Total Hip and Knee Arthr...
Low Risk of Thromboembolic Complications With Tranexamic Acid After Primary Total Hip and Knee Arthroplasty
About this item
Full title
Author / Creator
Publisher
New York: Springer-Verlag
Journal title
Language
English
Formats
Publication information
Publisher
New York: Springer-Verlag
Subjects
More information
Scope and Contents
Contents
Background
The use of antifibrinolytic medications in hip and knee arthroplasty reduces intraoperative blood loss and decreases transfusion rates postoperatively. Tranexamic acid (TXA) specifically has not been associated with increased thromboembolic (TE) complications, but concerns remain about the risk of symptomatic TE events, particularly w...
Alternative Titles
Full title
Low Risk of Thromboembolic Complications With Tranexamic Acid After Primary Total Hip and Knee Arthroplasty
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3528901
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3528901
Other Identifiers
ISSN
0009-921X
E-ISSN
1528-1132
DOI
10.1007/s11999-012-2488-z
